Small Cap Feast

27th April 2023

Dish of the day
No Joiners today
Off the menu
No leavers today
Dish Of The Day:

No joiners today.

Trian Investors 1 Limited has left the Specialist Fund Segment of the London Stock Exchange.

What’s Cooking In The IPO Kitchen?

Golden Metal Resources Plc a mineral exploration company focused on tungsten, gold, copper, silver and zinc within Nevada, USA intends to join AIM. It was established on 22 April 2021 as a company registered in England and Wales for the purpose of holding all of the Nevada mining assets of Power Metal Resources plc (AIM:POW). The Company holds four mining assets comprising the wholly owned Pilot Mountain, Garfield and Stonewall projects together with an earn-in option over the Golconda Summit project. Each of the projects consists of mining claims located entirely on land managed by the United States Bureau of Land Management. Expected Admission Early May 2023.

Ashoka WhiteOak Emerging Markets Trust Plc intends to join the Premium Segment of the London Stock Exchange. The Company is a new UK investment trust seeking to achieve long-term capital appreciation through investment primarily in quoted securities that provide exposure to global Emerging Markets and intends to raise £100m at 100p per ordinary share. Expected Admission 3 May 2023.

M7 Box+ REIT plc, a newly established, externally managed closed-ended investment company announces that it intends to join the Wholesale segment of IPSX. Upon Admission, the Company proposes to acquire a portfolio of seven let and operational e-warehouses from M7 Box+ II LP. As at 31 December 2022, the Property Portfolio was valued at £228.9m. Expected Admission April 2023

Breakfast Buffet

CT Automotive Group 39p £19.9m (CTA.L)
The UK-headquartered company that designs, develops and supplies interior components for the global automotive industry, announces the fundraising for gross proceeds of approximately £7.6m at an issue price of 34 pence per share. This consists of (1) approximately £5.1m (before expenses) from a placing; (2) approximately £100,620 from Director Subscription by Simon Phillips and Scott McKenzie will total; (3) approximately £2.4m from certain existing shareholders. The net proceeds of £7.2m will predominately be used to strengthen the balance sheet. A small portion of the net proceeds are expected to be deployed to realise further efficiency including through investment in injection moulding production processes and robotics.

HSS Hire Group 13.75p £96.8m (HSS.L)
The equipment hire in the UK and Ireland announces results for the year ended 31 December 2022. Total revenue increased 9.7% to £332.8m. Operating profit was £26.6m, up 6.9%. Profit before tax increased 198% to £18.9m, due to lower financing expenses. Net debt was £41,5m (FY21: £45.4m) reflecting improved profitability and working capital management. Capex investment in 2023 is expected to be £34-£38mm, including c£5m to support further delivery of the technology roadmap. The company is seeing revenue growth in Q1 2023. Management remains confident that full year EBITA will be in line with market expectations.

Kodal Minerals 0.77p £131.0m (KOD.L)
The exploration and development company focused on lithium and gold assets in West Africa, announces that the Company, Kodal's UK subsidiary Kodal Mining UK Limited (KMUK), Hainan Mining Co. Limited and Hainan's wholly owned UK-incorporated subsidiary Xinmao Investment Co. Limited have agreed to an extension of the deadline for the completion of the funding package announced on 19 January 2023 to 31 May 2023 (originally 30 April 2023). The extension will provide additional time for certain conditions precedent to be satisfied, including the transfer of the Bougouni Project to a new Mali mining company owned by KMUK.

Maintel Holdings 100p £14.4m ((MAI.L)
The provider of cloud and managed communications services, announces its audited results for the year to 31 December 2022. Revenue declined 12.4% to £91m, due to supply chain issues related to semiconductors in Q4 2021, delays in public-sector tenders and lower revenue from large project. Adjusted profit before tax was £1.6m, down 76.5%. A strategic review was completed in Q1 FY23, leading to a focus on higher margin product lines, adapting the delivery and support organisations for cost savings. Trading to date in FY23: revenue, EBITDA and orders are all in line with management expectations.

Molten Ventures 269.7p £412.6m (GROW.L)
The venture capital firm investing in high-growth digital technology businesses, announces an update on its portfolio ahead of its results for the year ended 31 March 2023. Gross Portfolio Value (GPV) (unaudited) is expected to be circa £1,370m (31 March 2022: £1,532m). Underlying Gross Portfolio decrease in fair value (unaudited) is approximately 19% at constant currency. A total of £138m (year to 31 March 2022: £311m) was invested from Molten’s balance sheet, with a further £41m from EIS and VCT co-investment. NAV per share (unaudited) is expected to be approximately 775p, down 17% (31 March 2022: 929p).

Mosman Oil & Gas 0.073p £5.1m (MSMN.L)
The oil exploration, development and production company, advises that it has secured a new lease adjacent to the Cinnabar lease in Texas, USA. Mosman is the Operator and Mosman will have a 78% working interest. award-winning television. The technical work identified the potential for the field to extend beyond the circa 350 acre Cinnabar lease. Mosman applied to BPX Energy to lease 120 acres of available acreage adjacent to the Cinnabar lease and BPX have now agreed to lease this area to Mosman et al. The principal terms of the lease are (1) a payment of US$36k (2) initial term of eighteen months that may be extended by the drilling and production of a well. Whilst there is production, the lease would be "Held by Production" (3) a Royalty of 25% of gross production (which is standard in this part of Texas).

Naked Wines 116.1p £85.9m (WINE.L)
The online wine retailer announces a pre-close trading update, based on unaudited financials, for the year ended 3rd April 2023. Total revenue was in line with guidance at c.£350m (flat on a reported basis, -6% to -8% on a comparable basis). Adjusted EBIT expected to be £15-18m, at the top end or slightly above the guided range. Net cash balance was £10m, supported by inventory reduction on track to guidance. As stated in January, the Company expects a modest revenue decline near-term but the demand outlook is stabilising. Naked Wines expect to generate cash in the second half of FY24 as stock levels reduce.

Novacyt 53.05p £36.0m (NCYT.L)
The international specialist in clinical diagnostics announces its audited results for the year ended 31 December 2022. Revenue was £21.0m (FY2021: £92.6m), in line with guidance due to the expected decline in COVID-19 related sales. EBITDA loss was £13.5m before exceptional items. Net cash at 31 December 2022 was £87.0m. Revenue for Q1 2023 is expected to be circa £1.7m (including £0.3m COVID-19 related). This has been a slower than expected particularly in instrumentation due to overhang of inventories that customers built up during the pandemic. Looking forward the Company expects the run-rate for both RUO and instrument sales to increase. Sales from its clinical portfolio are expected coming through towards the latter part of the year.

Synairgen 11.0p £22.2m (SNG.L)
The respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, announces its preliminary statement of audited results for the year ended 31 December 2022. Loss from operations was £20.3m (2021: £57.9m), with R&D expenditure decreasing to £14.9m (2021: £52.9m). Cash and deposit balances was £19.7m (31 December 2021: £33.8m). The Company believes that SNG001 has the potential to help the respiratory treatments for high-risk patient groups and looks forward to initiating the first trials in the second half of this year.

Tower Resources 0.1225p £4.7m (TRP.L)
The oil and gas company with a focus on Africa, is pleased to provide an update on its activities in respect of its Thali Production Sharing Contract (PSC) in the Rio Del Rey sedimentary basin offshore Cameroon. The company has applied for a one-year extension of the initial exploration period of the PSC, following positive discussions with the Minister of Mines, Industry and Technological Development and the Prime Minister of the Republic of Cameroon. Discussion for a term loan of approximately $7m with BGFI Bank Group is ongoing and the Company is also actively discussing asset-level financing with several parties.


27 April 2023
*A corporate client of Hybridan LLP or retained by Hybridan LLP for certain services
** Arranged by most recent first
*** Alphabetically arranged


Our daily digest of news from UK listed Small and Mid caps straight to your Inbox.


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email with “unsubscribe me”.

© Copyright 2024 - Hybridan | Website by Boxed Up Media
First Visit
bookcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram